| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/12/2008 | CN101138607A Sea snake bining sugar-coating tablets and preparation method thereof |
| 03/12/2008 | CN101138597A Traditional Chinese medicine preparation for preventing and controlling osteoporosis and method of preparing the same |
| 03/12/2008 | CN101138568A Application of hydrochloric acid in the preparation of medicament for treating diabetes and prostate gland disease |
| 03/12/2008 | CN101138566A Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds |
| 03/12/2008 | CN101138565A Platelet aggregation-against pharmaceutical composition and method of preparing the same |
| 03/12/2008 | CN101138560A Nitrofuran gelling agent and method of preparing the same |
| 03/12/2008 | CN101138559A Novel medicine preparations for curing psoriasis |
| 03/12/2008 | CN101138557A Chlorhexidine acetate partial film forming gel composition and uses thereof |
| 03/12/2008 | CN101138556A Terbinafine or its salt film forming gel composition and uses thereof |
| 03/12/2008 | CN101138554A Effervescence dispersible tablet |
| 03/12/2008 | CN101138551A Preparation method of lung targeting emodin polylactic acid microsphere and application in anti-mouse pulmonary fibrosis |
| 03/12/2008 | CN101138550A Mixed glue bundle pharmaceutical preparations produced in combination use of multiple surfactant and processes for their preparation |
| 03/12/2008 | CN101138548A Polyglycol derivatization phospholipid loaded vinorelbine nano-micelle preparations |
| 03/12/2008 | CN101138546A Restrainer containing tyrosine kinase and anticancer hormone medicines composition |
| 03/12/2008 | CN101138545A Clathrate compound containing ginsenoside Rg2 and method of preparing the same |
| 03/12/2008 | CN101138544A Diclofenac or the salt thereof partial film forming gel composition and uses thereof |
| 03/12/2008 | CN101138543A Centella asiatica partial film forming gel composition and uses thereof |
| 03/12/2008 | CN101138542A Lidocaine hydrochloride partial film forming gel composition and uses thereof |
| 03/12/2008 | CN101138541A Amlexanox partial film forming gel composition and uses thereof |
| 03/12/2008 | CN100374550C Magnetic cell and method of using the same |
| 03/12/2008 | CN100374468C Synthetic process for water soluble sulfoalkyl ether-beta-cyclic dextrine |
| 03/12/2008 | CN100374443C Hydrophilic polymer-thunder good vine extract binding substance and its medicinal composition |
| 03/12/2008 | CN100374163C Composition for the enhancement of the efficacy of drugs |
| 03/12/2008 | CN100374161C Triacetin as a transdermal penetration enhancer |
| 03/12/2008 | CN100374154C Sincalide formulations |
| 03/12/2008 | CN100374151C medicine compositions for generating immune and usage of prevention and treatment of amyloidogenic disease |
| 03/12/2008 | CN100374128C Leucoderma treating Chinese medicine |
| 03/12/2008 | CN100374110C Local preparation containing poloxamer and other microbe killing agent and applicator |
| 03/12/2008 | CN100374085C Method and apparatus for production of a skin graft and the graft produced thereby |
| 03/11/2008 | US7342047 useful in the preparation of hydrophilic gels; prepared from obligers having pendent hydrophilic poly(alkenylene oxide) groups, and pendent pulverizable functional groups, and cross linked by polyfunctional poly(alkenylene oxides); medical articles useful as wound dressings |
| 03/11/2008 | US7342045 Stabilized ascorbic acid solutions; use thereof; process for their obtention; and formulations comprising the same |
| 03/11/2008 | US7341999 Povidone-containing carriers for polypeptide growth factors |
| 03/11/2008 | US7341744 Administering aqueous soluble proanthocyanidin polymer isolated from a Croton species or a Calophyllum species; protective coating for oral administration |
| 03/11/2008 | US7341738 Lipid-encapsulated polyanionic nucleic acid |
| 03/11/2008 | CA2468929C Medical adhesive and medical covering agent using ultraviolet ray curable chitosan derivative |
| 03/11/2008 | CA2451924C Diagnostic agents for pancreatic exocrine function |
| 03/11/2008 | CA2444561C Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 03/11/2008 | CA2408548C Method for the preparation of polymeric micelle via phase separation of block copolymer |
| 03/11/2008 | CA2407747C Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts |
| 03/11/2008 | CA2402336C Concentrated solutions of carvedilol |
| 03/11/2008 | CA2396130C Preparation of irrigating solution for ocular surgery |
| 03/11/2008 | CA2391647C Biomolecular complex formed between hyaluronic acid and a biomolecule |
| 03/11/2008 | CA2377916C Taste masked pharmaceutical liquid formulations |
| 03/11/2008 | CA2290646C Triterpene saponin analogs having adjuvant and immunostimulatory activity |
| 03/11/2008 | CA2289756C Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties |
| 03/11/2008 | CA2284669C Improved dasc compositions, process for preparing same and suspensions containing same |
| 03/11/2008 | CA2271139C Percutaneous delivery system |
| 03/11/2008 | CA2270396C Cationic reagents for transfection |
| 03/11/2008 | CA2235177C New exocellular polysaccharide produced by streptococcus thermophilus |
| 03/11/2008 | CA2180856C Porous particle aggregate and method therefor |
| 03/11/2008 | CA2126091C Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 03/07/2008 | CA2599849A1 Synthetic platelets |
| 03/06/2008 | WO2008027993A2 Drug delivery systems comprising solid solutions of weakly basic drugs |
| 03/06/2008 | WO2008027793A2 Ophthalmic pharmaceutical compositions and uses thereof |
| 03/06/2008 | WO2008027395A2 Pharmaceutical compositions of benzodiazepines and methods of use thereof |
| 03/06/2008 | WO2008027357A2 Pharmaceutical compositions of clonazepam and methods of use thereof |
| 03/06/2008 | WO2008026776A1 Transdermal composition, transdermal pharmaceutical composition and transdermal cosmetic composition comprising polymer micelle encapsulating active ingredient |
| 03/06/2008 | WO2008026765A2 Lyophilized preparation |
| 03/06/2008 | WO2008026702A1 Pharmaceutical composition containing statin-encapsulated nanoparticle |
| 03/06/2008 | WO2008026644A1 Hydrophilic matrix having poorly water-soluble compound sealed therein, and method for producing the same |
| 03/06/2008 | WO2008026381A1 Nail patch |
| 03/06/2008 | WO2008026310A1 Protective agent for oral mucosa containing trehalose |
| 03/06/2008 | WO2008026295A1 Supporter |
| 03/06/2008 | WO2008025990A1 Biological materials and uses thereof |
| 03/06/2008 | WO2008025867A1 Compounds that act as a vehicle for delivery through the blood-brain barrier and charge delivery vehicle constructions |
| 03/06/2008 | WO2008025856A2 Modified glycoproteins |
| 03/06/2008 | WO2008025848A2 Composition for eliciting a specific ctl response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells |
| 03/06/2008 | WO2008025837A1 Improvements in pharmaceutical compositions |
| 03/06/2008 | WO2008025819A2 Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability |
| 03/06/2008 | WO2008025773A1 Pharmaceutical compositions comprising cefquinome |
| 03/06/2008 | WO2008025563A2 Polymer matrix, method for its production, and its use |
| 03/06/2008 | WO2008025560A1 Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy |
| 03/06/2008 | WO2008025528A1 Method for the production of conjugates of insulin-like growth factor-i and poly(ethylene glycol) |
| 03/06/2008 | WO2008025527A1 Method for the production of insulin-like growth factor-i |
| 03/06/2008 | WO2008025380A1 Medicament containing fluoroquinolones |
| 03/06/2008 | WO2008025228A1 The antibiotics composition comprising beta-lactam antibiotics and buffers |
| 03/06/2008 | WO2008025227A1 The antibiotics composition comprising aminoglycoside antibiotics |
| 03/06/2008 | WO2008025226A1 The antibiotics composition comprising beta-lactam antibiotics and ionic chelating agents |
| 03/06/2008 | WO2008025095A1 Method of eliciting or inducing an immune response |
| 03/06/2008 | WO2007133752A3 Formulations of 5-ht3 receptor antagonists with polyorthoester for use in the prevention of acute and delayed chemotherapy- induced nausea and vomiting (cinv) |
| 03/06/2008 | WO2007119011A3 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family |
| 03/06/2008 | WO2007111933A3 Pharmaceutical compositions comprising a hypoglycemic agent and methods of using same |
| 03/06/2008 | WO2007087131A3 Peptide prodrugs |
| 03/06/2008 | WO2007039825A3 Saccharide foamable compositions |
| 03/06/2008 | WO1999045887A3 Monolithic tablet for controlled drug release |
| 03/06/2008 | US20080058760 Use Of A Viscoelastic Composition For Treating Increased Intraocular Pressure |
| 03/06/2008 | US20080058733 Antibiotic(s)-polymer combination |
| 03/06/2008 | US20080058504 Polymer-factor VIII moiety conjugates |
| 03/06/2008 | US20080058502 Method for preparing microparticles having a selected polymer molecular weight |
| 03/06/2008 | US20080058429 Diagnosis Of Primary Open Angle Glaucoma |
| 03/06/2008 | US20080058428 Deodorizing an anion exchange resin by preparing a mixture of anion exchange resin having an undesirable odor and a cation exchange resin; volatile degradation products of amines and ammonia inhibited; deodorizing Amberlite" by neutralizing with Duolite"; organoleptic oral drug carriers |
| 03/06/2008 | US20080058427 Cyclodextrin-based polymers for therapeutics delivery |
| 03/06/2008 | US20080058416 Administering a ketogenic material to produce a ketosis to provide effects of antidepressants, anxiolytic agents, cognition activators, and/or analgesics; preferred materials produce such that the total concentration of acetoacetate and (R)-3-hydroxybutyrate in the blood is raised to 0.1-30 mM. |
| 03/06/2008 | US20080058404 Co-milling ramipril with lubricant selected from glyceryl behenate, polyethylene glycol, stearic acid, sodium stearyl fumarate, and combinations thereof; cardiovascular disorders; hypertension |
| 03/06/2008 | US20080058371 Bactericides; produces little or no tissue damage or irritation at the injection site |
| 03/06/2008 | US20080058306 Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitors(s) and treatments for vascular indications |
| 03/06/2008 | US20080058284 Pharmaceutical compositions of semicarbazones and/or thiosemicarbazones and/or their derivatives and products of these compositions and their uses as anticonvulsant, anti-nociceptive and anti-inflammatory agents, and in the angiogenic therapy |
| 03/06/2008 | US20080058270 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 03/06/2008 | US20080058249 Complexes |
| 03/06/2008 | US20080058246 Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity |